Brief: Alterity Therapeutics Receives A $4.74 Million Research & Development Tax Incentive Refund
15/08/2023 12:38
Alterity Therapeutics Ltd ATH.AX :
* ALTERITY THERAPEUTICS RECEIVES A $4.74 MILLION RESEARCH &
DEVELOPMENT TAX INCENTIVE REFUND
* ALTERITY THERAPEUTICS LTD - FUNDS WILL BE USED TO FURTHER
ALTERITY'S CLINICAL DEVELOPMENT AND RESEARCH ACTIVITIES
Source text for Eikon: ID:nGNX26Sw7l
Further company coverage: ATH.AX
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital